C M Asplin

962 total citations
27 papers, 707 citations indexed

About

C M Asplin is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Surgery. According to data from OpenAlex, C M Asplin has authored 27 papers receiving a total of 707 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Genetics and 7 papers in Surgery. Recurrent topics in C M Asplin's work include Diabetes Management and Research (11 papers), Diabetes and associated disorders (8 papers) and Hyperglycemia and glycemic control in critically ill and hospitalized patients (6 papers). C M Asplin is often cited by papers focused on Diabetes Management and Research (11 papers), Diabetes and associated disorders (8 papers) and Hyperglycemia and glycemic control in critically ill and hospitalized patients (6 papers). C M Asplin collaborates with scholars based in United Kingdom, United States and New Zealand. C M Asplin's co-authors include Thomas L. Paquette, M. Hartog, Paul J. Davis, Iain D. C. Fraser, Terry J. Hamblin, John Verrier Jones, R C Bucknall, D. J. Goldie, G László and R. H. Cumming and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and American Journal of Clinical Nutrition.

In The Last Decade

C M Asplin

27 papers receiving 615 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C M Asplin United Kingdom 13 268 178 175 113 107 27 707
Subir R. Maitra United States 15 134 0.5× 142 0.8× 44 0.3× 110 1.0× 182 1.7× 29 617
Philip M. LeCompte United States 13 409 1.5× 464 2.6× 392 2.2× 57 0.5× 106 1.0× 20 917
Jos Depovere Belgium 8 149 0.6× 67 0.4× 199 1.1× 142 1.3× 80 0.7× 11 768
Shoichi Tomono Japan 14 213 0.8× 128 0.7× 164 0.9× 33 0.3× 194 1.8× 41 686
Changchun Qiu China 18 290 1.1× 83 0.5× 257 1.5× 47 0.4× 223 2.1× 62 911
Dina Meytes Israel 16 57 0.2× 73 0.4× 74 0.4× 213 1.9× 137 1.3× 55 1.0k
Füsun Saygılı Türkiye 17 332 1.2× 107 0.6× 79 0.5× 53 0.5× 142 1.3× 65 757
Tjin‐Shing Jap Taiwan 15 383 1.4× 212 1.2× 209 1.2× 28 0.2× 295 2.8× 35 859
M. Thabet Canada 14 107 0.4× 108 0.6× 46 0.3× 114 1.0× 322 3.0× 40 752
D Melina Italy 11 48 0.2× 109 0.6× 110 0.6× 69 0.6× 65 0.6× 37 654

Countries citing papers authored by C M Asplin

Since Specialization
Citations

This map shows the geographic impact of C M Asplin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C M Asplin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C M Asplin more than expected).

Fields of papers citing papers by C M Asplin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C M Asplin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C M Asplin. The network helps show where C M Asplin may publish in the future.

Co-authorship network of co-authors of C M Asplin

This figure shows the co-authorship network connecting the top 25 collaborators of C M Asplin. A scholar is included among the top collaborators of C M Asplin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C M Asplin. C M Asplin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Booth, R, Judy Y. Weltman, Vladimir I. Yankov, et al.. (1996). Mode of pulsatile follicle-stimulating hormone secretion in gonadal hormone-sufficient and -deficient women--a clinical research center study.. The Journal of Clinical Endocrinology & Metabolism. 81(9). 3208–3214. 19 indexed citations
2.
South, Stephen A., C M Asplin, R Booth, et al.. (1993). Alterations in luteinizing hormone secretory activity in women with insulin-dependent diabetes mellitus and secondary amenorrhea.. The Journal of Clinical Endocrinology & Metabolism. 76(4). 1048–1053. 33 indexed citations
3.
Egan, Josephine M., et al.. (1991). Glucose-Stimulated Insulin Release by Individual Pancreatic   Cells: Potentiation by Glyburide. Experimental Biology and Medicine. 196(2). 203–209. 9 indexed citations
4.
Asplin, C M, et al.. (1991). Psyllium fiber reduces rise in postprandial glucose and insulin concentrations in patients with non-insulin-dependent diabetes. American Journal of Clinical Nutrition. 53(6). 1431–1435. 95 indexed citations
5.
Asplin, C M, et al.. (1986). SMS 201-995: Studies in Acromegaly and in Normal Menxs. Scandinavian Journal of Gastroenterology. 21(sup119). 243–248. 4 indexed citations
6.
Asplin, C M, Priscilla Hollander, & Jerry P. Palmer. (1984). How does glucose regulate the human pancreatic A cell in vivo?. Diabetologia. 26(3). 203–7. 2 indexed citations
7.
Asplin, C M, et al.. (1984). The Antibody Response to Insulin Therapy: A Prospective Study in HLA-typed Insulin-dependent Diabetic Subjects. Diabetes. 33(10). 966–969. 9 indexed citations
8.
Leonard, Robert, et al.. (1983). Acute respiratory distress in diabetic ketoacidosis: possible contribution of low colloid osmotic pressure.. BMJ. 286(6367). 760–762. 21 indexed citations
9.
Asplin, C M, T. D. R. Hockaday, Robin Smith, & R Andrew Moore. (1980). Detection of unrecognised nocturnal hypoglycaemia in insulin-treated diabetics.. BMJ. 280(6211). 357–360. 14 indexed citations
10.
Werner, Philipp, J W Benson, Jay B. Brodsky, et al.. (1980). Comparison of glucagon responses to 2-deoxy-D-glucose and hypoglycemia in man. American Journal of Physiology-Endocrinology and Metabolism. 239(3). E227–E231. 6 indexed citations
11.
Kohner, E M, et al.. (1979). Trauma and severe proliferative retinopathy in diabetes mellitus.. BMJ. 2(6194). 831.1–831. 4 indexed citations
12.
Moore, R Andrew, C M Asplin, & Robin Smith. (1979). SIMPLE TEST FOR NOCTURNAL HYPOGLYCÆMIA IN DIABETIC PATIENTS. The Lancet. 313(8113). 409–410. 15 indexed citations
13.
Asplin, C M, Nicholas J. Beeching, & Mary Slack. (1979). Osteomyelitis due to Streptococcus equisimilis (group C).. BMJ. 1(6156). 89.2–90. 12 indexed citations
15.
Asplin, C M, M. Hartog, & D. J. Goldie. (1978). THE RELATIONSHIP BETWEEN CIRCULATING FREE AND BOUND INSULIN, INSULIN ANTIBODIES, INSULIN DOSAGE AND DIABETIC CONTROL IN INSULIN TREATED DIABETICS. European Journal of Endocrinology. 87(2). 330–338. 17 indexed citations
16.
Asplin, C M, D. J. Goldie, & M. Hartog. (1977). The measurement of serum free insulin by steady-state gel filtration. Clinica Chimica Acta. 75(3). 393–399. 9 indexed citations
17.
Cumming, R. H., et al.. (1976). EVIDENCE FOR CIRCULATING IMMUNE COMPLEXES IN ERYTHEMA NODOSUM AND EARLY SARCOIDOSIS. Annals of the New York Academy of Sciences. 278(1). 212–219. 44 indexed citations
18.
Asplin, C M & M. Hartog. (1976). Hazards of monocomponent insulins. BMJ. 1(6018). 1146–1146. 2 indexed citations
19.
Jones, John Verrier, R C Bucknall, C M Asplin, et al.. (1976). PLASMAPHERESIS IN THE MANAGEMENT OF ACUTE SYSTEMIC LUPUS ERYTHEMATOSUS?. The Lancet. 307(7962). 709–711. 176 indexed citations
20.
Asplin, C M, et al.. (1976). CIRCULATING IMMUNE COMPLEXES IN ERYTHEMA NODOSUM AND EARLY SARCOIDOSIS. The Lancet. 307(7951). 153–153. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026